Cart summary

You have no items in your shopping cart.

TAS6417

SKU: orb1307699

Description

Zipalertinib (TAS6417, CLN-081) is a potent, orally bioavailable covalent EGFR inhibitor targeting the ATP-binding hinge region with low nM IC50 values. It is a research tool for investigating EGFR-driven cancers, demonstrating activity in both cellular assays and in vivo tumor models.

Research Area

Cardiovascular Research, Cell Biology, Signal Transduction

Images & Validation

Key Properties

CAS Number1661854-97-2
MW396.44
Purity99.71% (May vary between batches)
FormulaC23H20N6O
SMILESCC1=C[C@@H](Cn2c1c(-c1cnc3ccccc3c1)c1c(N)ncnc21)NC(=O)C=C
TargetEGFR,Apoptosis
SolubilityDMSO:55 mg/mL (138.73 mM);10% DMSO+40% PEG300+5% Tween-80+45% Saline:2.5 mg/mL (6.31 mM)

Bioactivity

Target IC50
EGFR:1.1-8.0 nM
In Vivo
METHODS: Nude mice bearing NIH/3T3 EGFR G719A allografts, nude mice bearing BID007, and nude mice bearing H1975 cells were treated with TAS6417 (50, 100, 200 mg/kg, oral, 15 days) to study the in vivo efficacy of Zipalertinib (TAS6417, CLN-081) against EGFR mutations. RESULTS Zipalertinib (TAS6417, CLN-081) inhibited tumor formation in nude mice bearing H1975, NIH/3T3 expressing G719A, NIH/3T3 expressing G719A+T790M, BID007, and H1975-insSVD.
In Vitro
METHODS: Two cell lines with EGFR exon 20 insertion isolated and established from lung cancer patients, BID007 and BID019, were treated with Zipalertinib (TAS6417, CLN-081) (0.001, 0.01, 0.1, 1, 10 μM). RESULTS Zipalertinib (TAS6417, CLN-081) inhibited EGFR phosphorylation in both cell lines at 10 nM and 100 nM.

Storage & Handling

Storagekeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

lung, inhibit, PC-9, NSCLC, H1975, ErbB-1, Epidermal growth factor receptor, EGFR, HER1, Inhibitor, Akt, Apoptosis, BID007, BID019, BEAS-2B, cancer, CLN081, CLN-081, CLN 081, TAS6417, TAS-6417, TAS 6417

Similar Products

  • TAS6417 [orb1218670]

    >98% (HPLC)

    1661854-97-2

    396.4

    C23H20N6O

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 g, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

TAS6417 (orb1307699)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 130.00
2 mg
$ 170.00
5 mg
$ 240.00
1 ml x 10 mM (in DMSO)
$ 270.00
10 mg
$ 370.00
25 mg
$ 710.00
50 mg
$ 930.00
100 mg
$ 1,230.00
200 mg
$ 1,670.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry